文献速递妇科

局部晚期宫颈癌女性近距离放疗实施与生存的种族差异

Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
PubMed 文献 · Gynecol Oncol · 2019-07-07

基于美国国家癌症数据库2004至2014年16116例IB2-IVA期宫颈癌女性的回顾性队列研究显示,黑人女性接受近距离放疗的比例显著更低(AOR 0.87,95%CI 0.79-0.96,p=0.007),全因死亡风险更高(中位生存3.9年 vs 非黑人女性5.2年,p<0.001)。未接受近距离放疗时黑人患者死亡风险增加(AHR 1.14,95%CI 1.05-1.24,p=0.002),而两组均接受近距离放疗时种族间生存无差异(AHR 1.04,95%CI 0.95-1.13,p=0.42;交互作用p=0.005)。

要点

  • 黑人女性接受近距离放疗的概率显著低于非黑人女性(AOR 0.87,95%CI 0.79-0.96)。
  • 未接受近距离放疗时黑人患者死亡风险显著增高(AHR 1.14,95%CI 1.05-1.24)。
  • 两组均接受近距离放疗时种族间生存无显著差异(AHR 1.04,95%CI 0.95-1.13)。

核心结论

  • 黑人局部晚期宫颈癌女性接受近距离放疗的可能性更低,这介导了种族间的生存差异。
  • 改善近距离放疗的可及性可能改善总生存。

研究设计与样本

  • 回顾性队列研究,使用美国国家癌症数据库2004至2014年16116例IB2-IVA期宫颈癌女性。
  • 排除未接受外照射放疗、生存数据或分期未知、以及子宫切除术后或盆腔廓清术后的患者。
  • 采用多因素logistic回归评估与近距离放疗使用相关的因素,并使用倾向评分调整的逆概率治疗加权模型计算总生存调整风险比,包含近距离放疗与种族的交互项。

主要发现

  • 16116例患者中19.2%为黑人,55.8%接受了近距离放疗。
  • 黑人女性接受近距离放疗的可能性显著更低(AOR 0.87,95%CI 0.79-0.96,p=0.007)。
  • 黑人女性全因死亡率更差,中位生存3.9年(95%CI 3.6-4.6) vs 非黑人女性5.2年(95%CI 4.9-5.5),p<0.001。
  • 在未接受近距离放疗的女性中,调整模型显示黑人患者死亡风险较非黑人患者增加(AHR 1.14,95%CI 1.05-1.24,p=0.002)。
  • 两组均接受近距离放疗时,种族间生存无差异(AHR 1.04,95%CI 0.95-1.13,p=0.42;交互作用p=0.005)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Black women have the highest incidence and mortality from cervical cancer in the United States. This study evaluated whether racial disparities in the receipt of brachytherapy (BT) for locally advanced cervical cancer mediate survival differences by race using the National Cancer Database. METHODS: A retrospective cohort study was performed using 16,116 women with stage IB2-IVA cervical cancer treated from 2004 to 2014. Women who did not receive external beam radiation therapy, those with unknown survival data or stage, and those status post hysterectomy or pelvic exenteration were excluded. Multivariate logistic regression was performed to evaluate factors associated with BT use. Using a propensity score adjusted model with inverse probability treatment weighting, adjusted hazard ratios for overall survival were calculated, including an interaction term between BT and race. RESULTS: Of 16,116 patients, 19.2% were black and 55.8% received BT. Black women were significantly less likely to receive BT (AOR 0.87, 95% confidence interval [CI] 0.79-0.96, p = 0.007) and had worse all-cause mortality (median survival 3.9 years [95% CI 3.6-4.6] versus 5.2 years [95% CI 4.9-5.5] for non-black women, p < 0.001). In the adjusted model, black patients had an increased risk of death compared to non-black patients (AHR 1.14, 95% CI 1.05-1.24; p = 0.002) among women who did not receive BT. However, there was no difference in survival by race when both groups received BT (AHR 1.04, 95% CI 0.95-1.13, p = 0.42; p-interaction = 0.005). CONCLUSIONS: Black women with locally advanced cervical cancer are less likely to receive brachytherapy, which mediates survival differences by race. Improving access to brachytherapy may improve overall survival.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Alimena S, Yang DD, Melamed A, et al. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer. Gynecol Oncol. 2019. PMID: 31292103. doi:10.1016/j.ygyno.2019.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。